Maternal blood test is more effective than standard screening for Down’s syndrome, study showsBMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h1797 (Published 02 April 2015) Cite this as: BMJ 2015;350:h1797
- Susan Mayor
Taking a blood sample from women at 10 to 14 weeks of pregnancy and analysing cell-free fetal DNA for an extra chromosome is more effective than standard non-invasive screening tests in diagnosing Down’s syndrome, a large multi-centre study has found.
The prospective study, reported in the New England Journal of Medicine,1 followed up pregnancy outcomes in nearly 16 000 women. The cell-free fetal DNA blood test correctly identified all 38 fetuses with Down’s syndrome, confirmed by examination of the newborn or by genetic analysis. This type of …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial